| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2004 | EP1450628A1 Powder formulation comprising conjugated octadecapolyenic acids |
| 09/01/2004 | EP1450626A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 09/01/2004 | EP1368041B1 Amphotericin b aqueous composition |
| 09/01/2004 | EP1347984B1 A process for the preparation of taxan derivatives |
| 09/01/2004 | EP1337228A4 Compositions for removing human cerumen |
| 09/01/2004 | EP1325044B1 Aqueous polymer dispersion |
| 09/01/2004 | EP1303245A4 Composition for topically delivering vitamin c |
| 09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
| 09/01/2004 | EP1274735A4 PROCESS FOR EXTRACTION OF $g(b)-GLUCAN FROM CEREALS AND PRODUCTS OBTAINED THEREFROM |
| 09/01/2004 | EP1274675B1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 09/01/2004 | EP1261349A4 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/01/2004 | EP1242410B1 Novel compounds |
| 09/01/2004 | EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | EP1223914B1 Orally distintegrating composition comprising mirtazapine |
| 09/01/2004 | EP1218012B1 Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis |
| 09/01/2004 | EP1194138A4 Nutritional supplements |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 09/01/2004 | EP1140851B1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP1123008A4 Preparation and use of solidified oils |
| 09/01/2004 | EP1089764B1 Stimulating the immune system |
| 09/01/2004 | EP1089745B1 Oregano for the treatment of internal parasites and protozoa |
| 09/01/2004 | EP1083880B1 Stable gel mixture in the form of a mixture of oleogel and aqueous gel |
| 09/01/2004 | EP1062261B1 Sulfonated comb polymers and preparations, especially hair cosmetic preparations based on such sulfonated comb polymers |
| 09/01/2004 | EP1037529A4 Composition useful for providing one-step surgical preparation and drape |
| 09/01/2004 | EP1027067B1 Use of substances having oxytocin activity for the preparation of medicaments for the treatment of affective pain syndromes |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0978278B1 4,5-dihydroxy-2-cyclopenten-1-one for the treatment of diabetes mellitus |
| 09/01/2004 | EP0978277B1 4,5-dihydroxy-2-cyclopentene-1-one for the treatment of rheumatism, inflammation and autoimmune diseases |
| 09/01/2004 | EP0974347B1 Antiviral agents |
| 09/01/2004 | EP0954296B9 Use of bronopol for the treatment of diseases in fish |
| 09/01/2004 | EP0944621B1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/01/2004 | EP0942729B1 Use of nk-1 receptor antagonists for treating stress disorders |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | EP0880502B1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 09/01/2004 | EP0835117B1 Ether derivatives of pseudopterosin |
| 09/01/2004 | EP0735864B2 Method for preparing low dose pharmaceutical products |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1525979A Bridged bicyclic serine protease inhibitors |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525974A Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 09/01/2004 | CN1525973A Dihydroimidazo[5,1-a]-beta-carboline derivatives, method for preparing same and use thereof as medicine |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525969A Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 09/01/2004 | CN1525967A N-苯基-2-嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivatives |
| 09/01/2004 | CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
| 09/01/2004 | CN1525962A De Rock Herman Augustinus |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525868A Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 09/01/2004 | CN1525866A Treatment using neublastin polypeptides |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525861A Method for treating ocular hypertension and glaucoma |
| 09/01/2004 | CN1525860A Novel therapeutic use of a thienylcyclohexylamine derivative |
| 09/01/2004 | CN1525859A Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 09/01/2004 | CN1525858A A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 09/01/2004 | CN1525857A Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 09/01/2004 | CN1525856A Stable high-concentration injection containing pyrazolone derivative |
| 09/01/2004 | CN1525855A Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 09/01/2004 | CN1525854A Remedies for allergic eye diseases |
| 09/01/2004 | CN1525852A Granules and granules coated with a masked taste |
| 09/01/2004 | CN1525851A Abuse-resistant controlled-release opioid dosage form |
| 09/01/2004 | CN1525850A Coenzyme Q10 containing microemulsion preconcentrates and microemulsions |
| 09/01/2004 | CN1525849A Olopatadine formulations for topical administration |
| 09/01/2004 | CN1525818A Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 09/01/2004 | CN1524960A Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 09/01/2004 | CN1524872A Active ingredient of jasmine root, extracting method and uses thereof |
| 09/01/2004 | CN1524871A Sekolamin saponin compound |
| 09/01/2004 | CN1524865A Crystalline forms of adefovir dipivoxil ester |
| 09/01/2004 | CN1524864A Bis phosphate, preparation and uses of its pharmaceutical preparations |
| 09/01/2004 | CN1524860A Cefetamet natrium, its preparing process and its application as antibacterial agent for injection |
| 09/01/2004 | CN1524859A Phenoxazones, preparing process and pharmaceutical uses thereof |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1524854A Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524852A Novel compounds with analgesic effect |
| 09/01/2004 | CN1524850A Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524608A Stable shaped particles of crystalline organic compounds |
| 09/01/2004 | CN1524580A Carmustine slow-release tablet and its preparation method |
| 09/01/2004 | CN1524579A Composite viscoelastic preparation |
| 09/01/2004 | CN1524558A Immunologic function booster for treating AIDS and SARS |
| 09/01/2004 | CN1524534A Polysaccharide sulphate for injection and its preparing process |
| 09/01/2004 | CN1524533A Pharmaceutical preparation ingested via nose for treating ischemia cerebrovascular disease |
| 09/01/2004 | CN1524532A Antineoplastic effect of a group of cycloart-one triterpene compound |
| 09/01/2004 | CN1524531A Compound terbinafine hydrochloride composition of skin antibacterial drugs |
| 09/01/2004 | CN1524530A Method for preparing ganciclovir intravenous fluid |
| 09/01/2004 | CN1524529A Pharmaceutical preparation and processe for platelet aggregation |
| 09/01/2004 | CN1524528A Medicament composition for treating coronary heart disease |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1524526A Double layer slow release preparation for nitrendipine |
| 09/01/2004 | CN1524525A Controlled release preparation for nitrendipine |
| 09/01/2004 | CN1524524A Controlled release preparation for nitrendipine of constant speed release |
| 09/01/2004 | CN1524523A Compound pressure-reduction preparation containing indapamide, angiotensin converzyme inhibitor and spironolactone |
| 09/01/2004 | CN1524522A Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor |
| 09/01/2004 | CN1524521A Troxerutin for injection and method for preparing the same |
| 09/01/2004 | CN1524520A Emergency protective agent for wound |